South San Francisco, CA, United States of America

Yoonha Choi

USPTO Granted Patents = 4 

Average Co-Inventor Count = 5.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
4 patents (USPTO):

Title: Yoonha Choi: Innovator in Medical Technology

Introduction

Yoonha Choi is a prominent inventor based in South San Francisco, CA. He has made significant contributions to the field of medical technology, particularly in the area of predictive analytics for treatment tolerability in lymphoma patients. With a total of 4 patents to his name, Choi's work is paving the way for improved patient outcomes.

Latest Patents

One of Yoonha Choi's latest patents focuses on "Predicting tolerability in aggressive non-hodgkin lymphoma." This innovative system and method aim to enhance the outcomes for subjects suffering from lymphoma. By utilizing advanced machine-learning models, the system allows for a more accurate prediction of which patients can tolerate specific treatments, potentially sparing them from conventional therapies that may lead to adverse effects. Another notable patent involves "Methods and systems for detecting usual interstitial pneumonia." This patent provides classifiers and methodologies to differentiate between samples as usual interstitial pneumonia (UIP) or non-UIP, showcasing Choi's versatility in addressing various medical challenges.

Career Highlights

Throughout his career, Yoonha Choi has worked with leading companies in the biotechnology sector, including Veracyte, Inc. and Genentech, Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions for complex medical issues.

Collaborations

Choi has collaborated with notable colleagues such as Giulia C Kennedy and Jing Huang. These partnerships have further enriched his research and development efforts, leading to groundbreaking advancements in medical technology.

Conclusion

Yoonha Choi's contributions to medical technology through his patents and collaborations highlight his commitment to improving patient care. His innovative approaches in predicting treatment tolerability and diagnosing conditions like interstitial pneumonia are making a significant impact in the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…